Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: best marker for monitoring and cost-effectiveness of different monitoring frequencies.
Lipid measurement is essential for calculating an individual’s overall risk of cardiovascular disease and coronary heart disease. We already know that using statins reduces coronary heart disease mortality among those at both moderate and high risk of CHD.
The overall aim of the project will be to identify the optimal strategies for monitoring lipid levels, including a cost-effectiveness model
For further inforamtion please conatct Emily McFadden
This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 10/97/01) and will be published in full in Health Technology Assessment